A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes
Clinical trial NCT01117103 · COMPLETED
Trial details
- NCT number
- NCT01117103
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 3592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.